Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.

@article{Ruepert2011BulkingAA,
  title={Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.},
  author={Lisa Ruepert and A. Quartero and N. D. de Wit and G. J. van der Heijden and G. Rubin and J. Muris},
  journal={The Cochrane database of systematic reviews},
  year={2011},
  volume={8},
  pages={
          CD003460
        }
}
BACKGROUND Irritable bowel syndrome (IBS) is a common chronic gastrointestinal disorder. The role of pharmacotherapy for IBS is limited and focused mainly on symptom control. OBJECTIVES The objective of this systematic review was to evaluate the efficacy of bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. SEARCH STRATEGY Computer assisted structured searches of MEDLINE, EMBASE, The Cochrane library, CINAHL and PsychInfo were conducted for the… Expand
Different interventions for the treatment of irritable bowel syndrome-adjusted indirect comparison
Moxibustion in the management of irritable bowel syndrome: systematic review and meta-analysis
Current and Emerging Pharmacotherapeutic Options for Irritable Bowel Syndrome
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 246 REFERENCES
Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis
Open-label treatment with citalopram in patients with irritable bowel syndrome: a pilot study.
...
1
2
3
4
5
...